Penson MG et al. |
Tacrolimus-based triple-drug immunosuppression minimizes serum lipid elevations in pediatric cardiac transplant recipients. |
1999 |
J. Heart Lung Transplant. |
pmid:10452348
|
Jones JW et al. |
Long-term survival of an extremity composite tissue allograft with FK506-mycophenolate mofetil therapy. |
1999 |
Surgery |
pmid:10455910
|
Miura S et al. |
The beneficial effects of FK 506 on living-related renal transplantation in presensitized recipients. |
1999 |
Transplant. Proc. |
pmid:10455940
|
Jiang H and Kobayashi M |
Differences between cyclosporin A and tacrolimus in organ transplantation. |
1999 |
Transplant. Proc. |
pmid:10455942
|
Kobashigawa JA |
Postoperative management following heart transplantation. |
1999 |
Transplant. Proc. |
pmid:10455966
|
Hachida M et al. |
Combined use of deoxyspergualin and FK 506 for temporary circulatory assist. |
1999 |
Transplant. Proc. |
pmid:10455968
|
Van Gelder RN and Kaplan HJ |
Immunosuppression in uveitis therapy. |
1999 |
Springer Semin. Immunopathol. |
pmid:10457590
|
Drachenberg CB et al. |
Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. |
1999 |
Transplantation |
pmid:10459544
|
Burke GA et al. |
The role of early renal biopsy in cyclosporin induced thrombotic microangiopathy. |
1999 |
Pediatr. Nephrol. |
pmid:10460501
|
Morris-Stiff GJ et al. |
Conversion from cyclosporin (Neoral) to tacrolimus (Prograf) in renal allograft recipients with chronic graft nephropathy: results of an observational study. |
1999 |
Transpl. Int. |
pmid:10460877
|
Gold BG |
FK506 and the role of the immunophilin FKBP-52 in nerve regeneration. |
1999 |
Drug Metab. Rev. |
pmid:10461545
|
Arndt C et al. |
Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans. |
1999 |
Microbiology (Reading, Engl.) |
pmid:10463165
|
Wandel C et al. |
P-glycoprotein and cytochrome P-450 3A inhibition: dissociation of inhibitory potencies. |
1999 |
Cancer Res. |
pmid:10463589
|
Alexanian AR and Bamburg JR |
Neuronal survival activity of s100betabeta is enhanced by calcineurin inhibitors and requires activation of NF-kappaB. |
1999 |
FASEB J. |
pmid:10463953
|
Shuto H et al. |
Inhibition of GABA system involved in cyclosporine-induced convulsions. |
1999 |
Life Sci. |
pmid:10465348
|
Ivery MT |
A proposed molecular model for the interaction of calcineurin with the cyclosporin A-cyclophilin A complex. |
1999 |
Bioorg. Med. Chem. |
pmid:10465413
|
Johnson CE and Truong NM |
Stability and compatibility of tacrolimus and fluconazole in 0.9% sodium chloride. |
1999 Jul-Aug |
J Am Pharm Assoc (Wash) |
pmid:10467814
|
Ogino Y et al. |
Comparison of cyclosporin A and tacrolimus concentrations in whole blood between jejunal and ileal transplanted rats. |
1999 |
J. Pharm. Pharmacol. |
pmid:10467956
|
Yokogawa K et al. |
P-glycoprotein-dependent disposition kinetics of tacrolimus: studies in mdr1a knockout mice. |
1999 |
Pharm. Res. |
pmid:10468022
|
Grassberger M et al. |
A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology. |
1999 |
Br. J. Dermatol. |
pmid:10468798
|